[1]JournalofMedicinalChemistry,2019,vol.62,p.8115-8139
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
138417-37-5
26029-13-0
26029-09-4
26029-08-3
26029-10-7
26028-64-8
261762-56-5 | 3-Chloro-2-fluoroanisole | AA002RYC | MFCD01631570
261951-78-4 | 1-Fluoro-2-methoxy-4-(trifluoromethyl)benzene | AA002S3T | MFCD01631564
262368-30-9 | N-(4-Aminophenyl)-n-methyl-2-(4-methylpiperazin-1-yl)acetamide | AA002SBU | MFCD12457658
2632-10-2 | 3,4-Dichlorophenacyl bromide | AA002SMV | MFCD00051581
26405-77-6 | Benzenemethanesulfonic acid, 3,4-dihydroxy-α-[(methylamino)methyl]- | AA002T0R | MFCD18432340
26494-76-8 | 4-Aminothiomorpholine 1,1-dioxide | AA002TDR | MFCD08276264
26591-66-2 | 2-Phenylmalondialdehyde | AA002TPD | MFCD03426041
275826-34-1 | (S)-3-Amino-3-(2-bromo-phenyl)-propionic acid | AA002U2N | MFCD04113674
27693-73-8 | Benzoic acid, 2-[(3-methoxyphenyl)amino]- | AA002UFB | MFCD01675236
27854-30-4 | 2H,2H,3H,3H-Perfluorononanoic acid | AA002UVI | MFCD00077579
54493-21-9
921993-70-6
Journal: Bioorganic & medicinal chemistry letters20101101